Win-Lwin Thuya Selected Research

17-dihydroexemestane

1/2015

Validation of a rapid and sensitive LC-MS/MS method for determination of exemestane and its metabolites, 17β-hydroxyexemestane and 17β-hydroxyexemestane-17-O-β-D-glucuronide: application to human pharmacokinetics study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Win-Lwin Thuya Research Topics

Disease

3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2016 - 07/2011
1	Breast Neoplasms (Breast Cancer) 01/2015
1	Liver Neoplasms (Liver Cancer) 01/2013
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2013
1	Hematologic Neoplasms (Hematological Malignancy) 01/2013
1	Hepatocellular Carcinoma (Hepatoma) 01/2013

Drug/Important Bio-Agent (IBA)

2	belinostatIBA 10/2016 - 01/2013
2	Histone Deacetylase InhibitorsIBA 10/2016 - 01/2013
2	Gefitinib (Iressa)FDA Link 03/2012 - 07/2011
2	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 03/2012 - 07/2011
1	Antineoplastic Agents (Antineoplastics)IBA 10/2016
1	RoscovitineIBA 10/2016
1	exemestane (Aromasin)FDA Link 01/2015
1	17-dihydroexemestaneIBA 01/2015
1	GlucuronidesIBA 01/2013

Therapy/Procedure

1	Therapeutics 07/2011